Challenges in implementing individualized medicine illustrated by antimetabolite therapy of childhood acute lymphoblastic leukemia.
about
Clinicians' expectations for gene-driven cancer therapyMercaptopurine metabolite levels are predictors of bone marrow toxicity following high-dose methotrexate therapy of childhood acute lymphoblastic leukaemia.Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner.Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia.Mass spectrometry based proteomics for absolute quantification of proteins from tumor cells.
P2860
Challenges in implementing individualized medicine illustrated by antimetabolite therapy of childhood acute lymphoblastic leukemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Challenges in implementing ind ...... acute lymphoblastic leukemia.
@en
Challenges in implementing ind ...... acute lymphoblastic leukemia.
@nl
type
label
Challenges in implementing ind ...... acute lymphoblastic leukemia.
@en
Challenges in implementing ind ...... acute lymphoblastic leukemia.
@nl
prefLabel
Challenges in implementing ind ...... acute lymphoblastic leukemia.
@en
Challenges in implementing ind ...... acute lymphoblastic leukemia.
@nl
P2860
P356
P1433
P1476
Challenges in implementing ind ...... acute lymphoblastic leukemia.
@en
P2093
Jacob Nersting
Louise Borst
P2860
P2888
P356
10.1186/1559-0275-8-8
P577
2011-06-03T00:00:00Z
P5875
P6179
1018583298